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Ⅰ．Introduction
　Neutrophils are the first line of defense of the 
innate immune system against infections. Recent 
studies have suggested that neutrophils also play 
additional roles in the immune response by 
producing chemokines that attract other immune 
cells to infectious foci and cytokines that modulate 
both innate and adaptive responses1）. Moreover, 
there is evidence that some cytokines produced 
by neutrophils may have a direct regulatory effect 
on the subsequent adaptive immune response2）. 
Thus, neutrophils play an integrated role in 
activation and regulation of the innate and 
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Abstract
　Human neutrophil elastase （HNE） induces NF-κB repressing factor （NKRF）, which inhibits 
chemokine synthesis. Obesity is a state of low-grade chronic inflammation and chemokine 
expression in inflamed adipose tissue is mainly mediated by nuclear factor kappaB （NF-κB）. 
We hypothesized that chemokine expression would differ between human visceral adipocytes 
cultured with or without HNE due to the influence of NKRF. 
　NKRF was detected in adipocytes from subjects with a body mass index （BMI） >30 kg/m2 
by western blotting and was upregulated by incubation with HNE, whereas NKRF was not 
detected in adipocytes from subjects with a BMI <30 kg/m2. Adipocytes from both groups of 
subjects expressed mRNA for monocyte chemoattractant protein-1 （MCP-1）, regulated on 
activation, normal T cell expressed and secreted （RANTES）, epithelial cell-derived neutrophil-
activating peptide-78 （ENA-78）, and interleukin-8 （IL-8）. However, only adipocytes from 
subjects with a BMI >30 kg/m2 expressed mRNA for lymphotactin-β and fractalkine. 
Incubation with HNE downregulated the expression of MCP-1 and RANTES mRNA and 
inhibited MCP-1 protein production by adipocytes from subjects with a BMI >30 kg/m2. 
Pretreatment of adipocytes with U73122 （a phospholipase C inhibitor） further reduced MCP-
1 mRNA expression and MCP-1 protein levels after incubation with HNE. While PAR-2 
agonists （LIGRLO and A264613） did not reduce MCP-1 mRNA expression, silencing of PAR-
2 blunted this response to HNE. In conclusion, HNE may modulate interactions between 
innate and adaptive immunity by altering the chemokine profile of visceral adipocytes.
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adaptive immune systems3, 4）. 
　Morbid obesity is associated with activation of 
the innate immune response .  Neutrophi ls 
transiently infiltrate intra-abdominal fat early in 
the course of feeding with a high-fat diet. This 
infiltration of neutrophils into adipose tissue 
precedes macrophage infiltration and is mediated 
by neutrophil CD11b and adipocyte ICAM-15）. 
Neutrophils express a functional leptin receptor 
and leptin stimulates neutrophil chemotaxis and 
oxidative bursts6）. In addition, apoptotic pathways 
are inhibited in neutrophils by activation of the 
leptin receptor7）. Infiltration of neutrophils into 
white adipose t issue occurs ear ly in the 
development of dietary obesity and is persistent5, 8）. 
Insulin resistance associated with obesity is a 
major risk factor for type 2 diabetes and 
cardiovascular disease, and chronic inflammation 
characterized by T cell and macrophage infiltration 
of visceral adipose tissue is a hallmark of obesity-
associated insulin resistance and glucose intolerance. 
Moreover, insulin resistance in obese persons is 
associated with a unique IgG autoantibody profile, 
suggesting the importance of B cells and adaptive 
immunity in the mechanisms under ly ing 
resistance to insulin9）. Interestingly, cells of the 
adaptive immune system, specifically B and T 
lymphocytes, have emerged as unexpected 
promoters and regulators of insulin resistance10）. 
This finding suggests the existence of a link 
between innate and adaptive immunity through 
cell-mediated and humoral immune responses. 
Thus, chemokines are key players in linking 
innate immunity with adaptive immunity11, 12）, 
while neutrophils are involved in the activation, 
regulation, and effector functions of innate and 
adaptive immune cells. Neutrophil effector 
molecules include a broad array of cytokines and 
extracellular traps. It has also been reported that 
neutrophils mediate insulin resistance in mice fed 
a high-fat diet through secretion of elastase8）. 
Human neutrophil elastase （HNE） represses the 
synthesis of IL-8 by human airway smooth muscle 
cells through induction of NF-κB repressing 
factor （NKRF）13）. NKRF is a transcriptional 
silencing protein that specifically counteracts the 
basal activity of several NF-κB-dependent 
promoters by binding directly to specif ic 
neighboring DNA sequences14）. HNE induces 
NKRF, which inhibits chemokine synthesis by 
peripheral blood mononuclear cells and alveolar 
macrophages15）. Thus, HNE may modulate 
chemokines produced by the target genes of NF-
kB. The present study was performed to 
investigate the influence of NKRF induced by 
HNE on the chemokine profile of human visceral 
adipocytes. 
Ⅱ．Materials and Methods
1. Ethics Statement 
　Human cryopreserved preadiocytes were 
obtained from Zen-Bio, Inc. （Research Triangle Park, 
NC）. The study utilizing human preadipocytes 
was approved by the Kumamoto Health Science 
University Institutional Review Board. 
2. Chemicals and reagents
　HNE with an act ivity of 0 .2 U/mL was 
purchased f rom SERVA Electrophores i s 
（Heidelberg, Germany）. U73122 （Merck Millipore, 
Bedford, MA） and two protease-activated receptor 
（PAR）-2 agonists （AC- 264613 [2-oxo-4-
phenylpyrrolidine-3-carboxylic acid [1-（3-bromo-
phenyl）-（E/Z）-ethylidene]-hydrazide], Tocris 
Bioscience, Bristol, UK and 2-furoyl-LIGRLO-
amide, Tocris Bioscience） were purchased to study 
the intracellular signal transduction pathways 
involved in PAR-2 stimulation. All reagents and 
chemicals were negative for endotoxin, as 
determined by an Endospecy test 16）.
3. Human visceral adipocytes
　Human visceral preadipocytes were supplied by 
Zen-Bio, Inc. （Research Triangle Park, NC）, 
cultured and differentiated into adipocytes 
according to the company’s instructions. Briefly, 
these f ibroblast - l ike precursor cel ls were 
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cryopreserved at the end of primary culture and 
thus could be propagated for two passages prior 
to differentiation into human adipocytes. In brief, 
human visceral preadipocytes （2.5×104 cells/well） 
were cultured in 12-well plates containing 
preadipocyte medium （DS Pharma Biomedical Co., 
Ltd., Suita, Japan） in a humidified incubator at 
37 ℃ under 5% CO2. At 24 h after plating, cells 
were checked for confluence and differentiation 
was induced with the differentiation medium 
according to the manufacturer’s instructions. At 2 
weeks after the initiation of differentiation, cells 
were rounded with large lipid droplets in the 
cytoplasm. These cells were considered to be 
mature adipocytes.
4. Extraction of RNA and reverse transcription 
polymerase chain reaction （RT-PCR）.
　Visceral adipocytes （2.5×104 cells） were extracted 
with 1 ml of ISOGEN RNA kit （NIPPON GENE, 
Toyama, Japan）. Total RNA was isolated and 
precipitated according to the manufacturer's 
instructions, after which 200 ng of total RNA was 
reverse-transcribed using Origo dT primer with 
PrimeScriptTM RT reagent Kit （TAKARA BIO, 
Shiga, Japan）. Then reverse-transcribed RNA was 
amplified by PCR using an TaKaRa PCR thermal 
cyc ler  （TAKARA BIO）.  The chemokine 
production profile of visceral adipocytes was 
determined by RT-PCR. In addition, visceral 
adipocytes were incubated with HNE （0 or 50 μM） 
for 6 hours, after which chemokine mRNA 
expression was analysed by RT-PCR. The primer 
sequences used were as follows: adiponectin 
forward,
5 ' -AGACTGGGCCTCCTGAATTT-3 ' ,  and 
reverse, 
5 '-TGTTCAGAATTTAAAACTGTAAGCA
AA-3'; forward, 
5 '-AGAAGCCTTATTGGTAAGGTT-3' and 
reverse 
5'-AACATCATGACAGGTGGTGAT-3' （PAR-2）; 
forward, 
5'-CAAACTGAAGCTCGCACTC-3' and reverse 
5'-CATTTCCACAATAATATTTTAG-3' （MCP-
1）; forward, 
5'-CTACTCGGGAGGCTAAGGCAGGAA-3' and 
reverse 
5 ' - G A G G G G T T G A G A C G G C G G A A G C - 3 ' 
（RANTES）; forward 
5 '-ATCTCCGCTCCTCCACCCAGT-3 '  and 
reverse 
5'-TTCTTGTCTTCCCTGGGTTCAGA-3' （ENA-
78）; forward 
5'-GCTTTCTGATGGAAGAGAGC-3' and reverse 
5'-GGCACAGTGGAACAAGGACT-3 （IL-8）; 
forward 
5'-TCTGCTCTCTCACTGCATAC-3' and reverse 
5 ' - C A G C T G T A T T G G T C G A T T G C - 3 ' 
（Lymphotactin- β）; forward 
5'-AGGAGAATGCTCCGTCTGAA-3' and reverse 
5 ' - A G A A G A G G A G G C C A A G G A A G - 3 
（Fractalkine）; forward 
5'-CTTGTGTAGAGATATAGCCAGG-3' and 
reverse
5'- GGGAACAAAAGTGAATGTGACC-3' （Tissue 
factor （TF））; forward 
5'-GTGGGGCGCCCCAGGCACCA-3' and reverse 
5 '-CTCCTTAATGTCACGCACGATTTC-3' 
（beta-Actin）. The PCR conditions were as 
follows: for adiponectin, 40 cycles （94 ℃ for 30 
seconds, 55 ℃ for 30 seconds, 72 ℃ for 
30 seconds）, PAR-2, 45 cycles （94 ℃ for 60 
seconds, 60 ℃ for 60 seconds, 72 ℃ for 60 
seconds）, MCP-1, 35 cycles （94 ℃ for 60 seconds, 
55 ℃ for 60 seconds, 72 ℃ for 60 
seconds）, RANTES, 45 cycles （94 ℃ for 60 
seconds, 60 ℃ for 60 seconds, 72 ℃ for 60 
seconds）, ENA-78, 45cycles （94 ℃ for 60 seconds, 
60 ℃ for 60 seconds, 72 ℃ for 60 
seconds）, IL-8, 35 cycles （94 ℃ for 60 seconds, 
55 ℃ for 60 seconds, 72 ℃ for 60 
seconds）, Lymphotactin-β, 45 cycles （94 ℃ for 60 
seconds, 60 ℃ for 60 seconds, 72 ℃ 
for 60 seconds）, Fractalkine, 45 cycle （94 ℃ for 60 
seconds, 60 ℃ for 60 seconds, 
72 ℃ for 60 seconds）, TF, 35 cycles （94 ℃ for 30 
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seconds, 55 ℃ for 30 seconds, 72 ℃ 
for 30 seconds ）, beta-Actin, 40 cycles （94 ℃ for 
30 seconds, 60 ℃ for 30 seconds, 
72 ℃ for 30 seconds ） were used. The PCR 
products were analyzed on agarose gels. 
5. Protease-activated receptor （PAR）-2 expression 
by visceral adipocytes
　G protein-coupled receptor signaling regulates 
obesity17） and modulates macrophage-dependent 
inflammation of adipose tissue18）. PAR-2 signals 
via G protein for activation. PAR-2 mRNA levels 
were investigated by RT-PCR to explore whether 
exposure to HNE （50μM） influenced PAR-2 mRNA 
expression by visceral adipocytes.
6. Chemokine profile of visceral adipocytes
　Expression of mRNA for monocyte chemoattractant 
protein-1 （MCP-1/CCL2）, regulated on activation, 
normal T cell expressed and secreted （RANTES/
CCL5）, epithelial cell-derived neutrophil-activating 
peptide-78 （ENA-78/CXCL5）, IL-8 （CXCL8）, 
lymphotactin-β （XCL2）, and fractalkine （CX3CL1） 
was investigated in visceral adipocytes from 
subjects with a BMI <30 kg/m2 or >30 kg/m2 to 
assess differences of the chemokine profile.
7. Western blotting for NF-κB repressing factor 
（NKRF）
　Adipocytes from subjects with a BMI <30 kg/
m2 or >30 kg/m2 were treated with HNE （0 or 50 
μM） for 6 hours and then NKRF was detected by 
Western blotting. Equivalent amounts of whole-
cell lysates from adipocytes were subjected to 
electrophoresis and the products were transferred 
to polyvinylidene difluoride membranes. Then the 
membranes were incubated with 1.0×103μg/L 
rabbit anti-human NF-κB repressing factor IgG 
（Abcam Inc., Cambridge, MA）, washed, and 
incubated with alkaline phosphatase-conjugated 
guinea pig anti-rabbit IgG （Abcam Inc.） diluted to 
1:4000. Next, the membranes were incubated with 
a chemiluminescence enhancer （Immun-Star, Bio-
Rad, Hercules, California） and exposed to XAR 
film （Kodak, Rochester, NY）. After the film was 
developed, bands were quantified with a densitometer 
and ImageQuant software （Molecular Dynamics, 
Sunnydale, CA）.
8. Effect of HNE on MCP-1 mRNA expression by 
visceral adipocytes 
　Visceral adipocytes obtained from subjects with 
a BMI <30 kg/m2 or >30 kg/m2 were incubated 
with or without HNE （50μM） for 6 h and then 
the level of MCP-1 mRNA was determined by 
reverse transcription and polymerase chain 
reaction （RT-PCR）. Differential effect of HNE on 
MCP-1 and tissue factor expression by visceral 
adipocytes. 
　Visceral adipocytes from subjects with a BMI 
>30 kg/m2 were incubated with or without HNE 
（50μM） for 6 h, after which MCP-1 and tissue 
factor （TF） mRNA levels were determined by 
RT-PCR. 
9. Effect of PAR-2 agonists on MCP-1 mRNA 
expression by visceral adipocytes
　A native peptide agonist （neutrophil elastase）, a 
synthetic peptide agonist （2-furoyl-LIGRLO-
amide）, or a non-peptide （AC-264613） agonist 
were employed for this experiment. Visceral 
adipocytes from subjects with a BMI >30 kg/m2 
were incubated with or without HNE （50μM） for 
6 hr. Adipocytes pretreated with U73122 （10 mM） 
were also incubated with HNE （50μM）. LIGRLO 
（1 mM） and AC- 264613 （5 mM） were utilized to 
investigate the influence of PAR-2 on chemokine 
production.
10. Enzyme-linked immunosorbent assay （ELISA） 
for MCP-1
　Visceral adipocytes from subjects with a BMI 
>30 kg/m2 were incubated with or without HNE 
（50μM） for 6 h. Then the level of MCP-1 protein 
in whole cell lysates was measured by ELISA 
（Abcam, Inc., Cambridge, MA） with an anti-
MCP-1 monoclonal antibody.
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11. Effect of silencing PAR-2 on MCP-1 production 
by visceral adipocytes after stimulation with HNE
　siRNA for PAR-2 was purchased from Santa 
Cruz Biotechnology. Transfection of mature 
visceral adipocytes from subjects with a BMI >30 
kg/m2 was performed using siRNA for PAR-2 （50 
nM） and LipofectamineTM RNAiMAX （Life 
Technologies, Carlsbad, CA） according to the 
manufacturer ’s protocol .  The transfected 
adipocytes （2.5×104 cells） were incubated with or 
without HNE （50μM） for 6 hr and MCP-1 protein 
levels in whole-cell lysates were determined by 
ELISA with an anti-MCP-1 monoclonal antibody 
（Abcam）.
12. Statistical analysis
　Results are expressed as the mean ± SE. 
Analysis of variance and the t-test of independent 
means were used to assess differences between 
multiple group and differences between two 
groups, respectively. When the F ratio was 
significant, mean values were compared by using 
a post hoc Bonferroni test. A P value <0.05 was 
considered to indicate a significant difference in all 
analyses.
Ⅲ．Results
　Western blotting revealed NKRF expression in 
visceral adipocytes from subjects with a BMI >30 
kg/m2, whereas it was not found in adipocytes 
from subjects with a BMI <30kg/m2. Interestingly, 
incubat ion with HNE upregulated NKRF 
expression by adipocytes from subjects with a 
BMI >30 kg/m2 （Fig. 1）. Visceral adipocytes from 
subjects with a BMI >30 kg/m2 expressed mRNA 
for monocyte chemoattractant protein-1 （MCP-1/
CCL2）, regulated on activation, normal T cell 
expressed and secreted （RANTES/CCL5）, 
epithelial cell-derived neutrophil-activating 
peptide-78 （ENA-78/CXCL5）, interleukin-8 （IL-8 
/CXCL8）,  lymphotac t in-β （XCL2）,  and 
fractalkine （CX3CL1）. Expression of MCP-1 and 
RANTES mRNA repressed significantly after 
exposure of adipocytes to HNE （50μM）, whereas 
beta-Actin was not affected. PAR-2 mRNA 
expression was not affected by exposure to HNE 
（Fig.2）. Although visceral adipocytes from 
subjects with a BMI <30 kg/m2 also showed 
expression of MCP-1, RANTES, ENA-78, and 
IL-8 mRNA, neither lymphotactin-beta nor 
fraktalkine mRNA was detected. Incubation of 
these cells with HNE did not repress the MCP-1 
or RNTES mRNA level （Fig. 3）. Next, we 
investigated the effects of HNE on expression of 
chemokines, MCP-1, and the prothrombotic 
molecule tissue factor （TF） by adipocytes from 
subjects with a BMI >30 kg/m2. TF expression 
was detected in unstimulated adipocytes . 
Exposure of these cel ls to HNE caused a 
repression of MCP-1 mRNA expression, whereas 
TF mRNA was upregulated. Protein level of 
MCP-1 was significantly decreased in the lysates 
of adipocytes （2.5×104 cells） incubated with HNE 
（50μM） compared to the lysates of adipocytes 
incubated without HNE （Fig.4）. Pretreatment of 
visceral adipocytes from subjects with a BMI >30 
kg/m2 by a phospholipase C inhibitor （U73122） 
led to a further decrease of MCP-1 mRNA after 
exposure of the cells to HNE. In contrast, PAR-2 
agonists （2-furoyl-LIGRLO-amide and AC- 
264613） did not reduce MCP-1 expression （Fig. 5）. 
Finally, silencing of PAR-2 did not blunt MCP-1 
production by visceral adipocytes stimulated with 
HNE （Fig. 6）.
Ⅳ．Discussion
　Expression of NKRF was detected by western 
blotting in visceral adipocytes from subjects with 
a BMI >30 kg/m2, whereas it was not found in 
adipocytes from subjects with a BMI <30 kg/m2. 
Incubat ion with HNE upregulated NKRF 
expression in visceral adipocytes from subjects 
with a BMI >30 kg/m2. Interestingly, HNE （50μM） 
significantly decreased expression of MCP-1 and 
RANTES mRNA by visceral adipocytes from 
subjects with a BMI >30 kg/m2 and both MCP-1 
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and RANTES are direct targets of NF-κB 19, 20）. In 
contrast, neither MCP-1 nor RANTES mRNA was 
downregulated in visceral adipocytes from 
subjects with a BMI <30 kg/m2, which is why 
NKRF was not detected in these visceral 
adipocytes by western blotting.
　Serine proteases have various important 
physiological roles that are mediated via G 
protein-coupled protease-activated receptors 
（PARs） and PAR-2 is a trypsin-activated member 
of the G-protein-coupled PAR family21）. Neutrophil 
elastase may influence cell signaling by targeting 
PAR-222）. Next, we investigated the influence of 
PAR-2 agonists on MCP-1 mRNA expression 
using 2-furoyl-LIGRLO-NH2, a PAR-2-activating 
peptide with modification of the N-terminal furoyl 
group that increases intracellular calcium more 
potently than SLIGRL-NH223） and has been shown 
to be a selective agonist of PAR-2 over PAR-1 24）. We 
also used AC 264613 [2-oxo-4-phenylpyrrolidine-3-
carboxylic acid [1-（3-bromo-phenyl）-（E/Z）
-ethylidene]-hydrazide], a low molecular weight 
PAR-2 agon is t ,  s t imulates  hydro lys i s  o f 
phosphatidylinositol and Ca2+ mobilization, and 
does not act on other PAR receptor subtypes25）. 
We found that PAR-2 agonists （2-furoyl-
LIGRLO-NH2 and AC-264613） did not reduce 
MCP-1 mRNA expression in visceral adipocytes 
from subjects with a BMI >30 kg/m2. It has been 
reported that U73122 （a phosphol ipase C 
inhibitor） suppresses phosphorylation of p65 and 
its translocation into the nucleus. Thus, activation 
of NF-κB is inhibited by U7312226）, which explains 
why we found that U73122 caused a further 
decrease of MCP-1 mRNA expression in cells 
exposed to HNE.
　It has been reported that expression of IL-8 27）, 
ENA-7828）, lymphotactin-β29）, and fractalkine30） is 
associated with increased activity of NF-κB. However, 
none of these mRNAs showed downregulation by 
HNE through induction of NKRF. HNE induces 
the production of MUC5AC mucin via generation 
of reactive oxygen species （ROS） and activation 
of transforming growth factor （TGF）-alpha-
dependent epidermal growth factor receptor 
（EGFR）. Tumor necrosis factor （TNF）-alpha-
converting enzyme （TACE） cleaves pro-TGF-
alpha to release soluble TGF-alpha and is 
activated by ROS31）. TACE （also known as ADAM 
metallopeptidase domain 17: ADAM17） is a member 
of the ADAM （a disintegrin and metalloprotease 
domain） family32）. TACE/ADAM17 has been 
reported to promote transactivation of EGFR in 
response to HNE. The TACE/TGF-α /EGFR axis 
regulates IL-8/CXCL833） and ADAM17 regulates 
ENA-78/CXCL534）. The membrane-bound form of 
fractalkine is generated by ADAM17 together 
with ADAM10 and35, 36）. Fractalkine was originally 
identified on the basis of its sequence homology to 
lymphotactin （XCL1）, a C-type chemokine. It is a 
transmembrane protein in which the chemokine 
domain sits on a mucin-like stalk, and the 
characteristic cysteines are separated by 3 amino 
acids37）. The extracellular domain is shed by 
proteolysis with ADAM10 to produce a soluble 
form, while shedding induced by phorbol-12-
myristate-13-acetate （PMA） is mediated by 
TACE/ADAM1735, 37, 38）. Thus, expression of IL-8, 
ENA-78, lymphotactin-beta, and fractalkine 
mRNA was upregulated by TACE/ADAM17 in 
response to incubation of cells with HNE.
　In this study, we found that HNE reduced 
MCP-1 expression. Tumor necrosis factor （TNF）-
α has been implicated as a causative factor in 
obesity-associated insulin resistance and the 
pathogenesis of type 2 diabetes39）. Interleukin 
（IL-4） or IL-10 is a potent inhibitor of TNF- α 
expression40, 41）. MCP-1 stimulates IL-4 and IL-10 
production41）. Indeed, MCP-1 is involved in Th2 
polarization by IL-4 or IL-1042）. Interestingly, it 
was reported that MCP-1-/- mice injected with 
lipolysaccharide （LPS） showed higher levels of 
TNF- α compared to LPS-treated MCP-1+/+ 
mice43）. Taken together, it is possible that MCP-1 
is associated with the Th1/Th2 imbalance which 
occur in obesity.
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V. conclusion
　HNE induced NF-kB repressing factor and 
altered the chemokine profile of human visceral 
adipocytes, suggesting that it may modulate the 
relation between innate and adaptive immunity in 
obesity-related diseases.
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Figure 1. Western blotting for NF- κB repressing factor （NKRF）
　After adipocytes from subjects with a BMI >30 kg/m2 or <30 kg/m2 were incubated with HNE （50μ
M） or without HNE for 6 hours, NKRF was detected by western blotting. Beta-actin was also detected in 
adipocytes with or without HNE stimulation. The density of each NKRF band was normalized to that of 
beta-actin.HNE: human neutrophil elastase. Samples were run in triplicate and three separate 
experiments were performed. （a） Representative western blot. （b） Densitometry data. Data were 
obtained using cells from three donors in each experiment （mean + SE）. *P< .01; N.S., not significant
1. Visceral adipocytes from subjects with a BMI >30 kg/m2 + HNE （50μM）
2. Visceral adipocytes from subjects with a BMI >30 kg/m2 （no HNE）
3. Visceral adipocytes from subjects with a BMI <30 kg/m2 + HNE （50μM）
4. Visceral adipocytes from subjects with a BMI <30 kg/m2 （no HNE）
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Figure 2. Chemokine profile of visceral adipocytes from subjects with a BMI >30 kg/m2 after incubation 
with or without HNE stimulation
a. RT-PCR identified expression of MCP-1, RANTES, ENA-78, IL-8, lymphotactin-beta, and fractalkine 
mRNA. Expression of MCP-1 and RANTES mRNA was significantly repressed by exposure to HNE （50
μM）. HNE had no inhibitory effect on PAR-2 mRNA expression. b. The density of each band was 
normalized to that of beta-actin. Data were obtained from three donors in each group and represent the 
mean + SE. *P< .01; N.S., not significant 
　1. 100 bp ladder 　2. β -Actin: HNE （50μM） 　3. β -Actin: HNE （0μM）
　4. MCP-1: HNE （50μM） 　5. MCP-1: HNE （0μM） 　6. RANTES: HNE （50μM）
　7. RANTES: HNE （0μM） 　8. ENA-78: HNE （50μM） 　9. ENA-78: HNE （0μM）
10. IL-8: HNE （50μM） 11. IL-8: HNE （0μM） 12. Lymphotactin-β : HNE （50μM）
13. Lymphotactin- β : HNE （0μM） 14. Fractalkine: HNE （50μM） 15. Fractalkine: HNE （0μM）
16. PAR-2: HNE （50μM） 17. PAR-2: HNE （0μM 
c. HNE （50μM） did not repress beta-Actin mRNA expression. The density of each band was normalized 
to that of beta-actin. HNE; human neutrophil elastase. Data were obtained from three donors in each 
group and represent the mean + SE. *P< .01; N.S., not significant
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Figure 3. Chemokine profile of visceral adipocytes from subjects with a BMI <30 kg/m2 after incubation 
with or without HNE
a. RT-PCR detected the expression of MCP-1, RANTES, ENA-78, and IL-8 mRNA, but neither 
lymphotactin-beta nor fractalkine mRNA was detected. MCP-1 mRNA was not repressed by HNE （50μM）. 
b. The density of each band was normalized to that of beta-actin. Data were obtained from three donors 
in each group and represent the mean + SE. N.S., not significant
　1. 100 bp ladder 　2. β -Actin: HNE （50μM） 　3. β -Actin: HNE （0μM
　4. MCP-1: HNE （50μM） 　5. MCP-1: HNE （0μM） 　6. RANTES: HNE （50μM）
　7. RANTES: HNE （0μM） 　8. ENA-78: HNE （50μM） 　9. ENA-78: HNE （0μM）
10. IL-8: HNE （50μM） 11. IL-8: HNE （0μM） 12. Lymphotactin- β : HNE （50μM）
13. Lymphotactin- β : HNE （0μM） 14. Fractalkine: HNE （50μM） 15. Fractalkine: HNE （0μM）
16. PAR-2: HNE （50μM） 17. PAR-2: HNE （0μM）
b. HNE （50μM） did not reduce beta-actin mRNA expression. The density of each band was normalized 
to that of beta-actin. HNE; human neutrophil elastase. Data were obtained from three individuals in each 
group and represent the mean ± SE. N.S., not significant
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Figure 4. Effect of HNE on MCP-1 and TF mRNA expression by adipocytes from subjects with a BMI 
>30 kg/m2
a.TF mRNA was detected in adipocytes derived from cryopreserved preadipocytes. HNE （50μM） 
repressed MCP-1 mRNA expression, although TF mRNA was upregulated. The density of each band 
was normalized to that of beta-actin （b）. Data were obtained from three donors in each group and 
represent the mean ± SE. *P< .01; N.S., not significant
　1. 100 bp ladder 　2. β -Actin:HNE （0μM）
　3. β -Actin:HNE （50μM） 　4. MCP-1: HNE （0μM）
　5. MCP-1: HNE （50μM） 　6. TF: HNE （0μM）
　7. TF: HNE （50μM）
c. MCP-1 was significantly decreased in lysates of adipocytes （2.5×104 cells） stimulated with HNE （50μ
M） compared to lysates of cells cultured without HNE. HNE; human neutrophil elastase. Data were 
obtained from three individuals in each group and represent the mean ± SE. *P< .01; N.S., not significant
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Figure 5．Effect of PAR-2 agonists on MCP-1 mRNA expression by adipocytes from subjects with a 
BMI >30 kg/m2
　Treatment of visceral adipocytes with HNE （50μM） partially inhibited MCP-1 mRNA expression. 
Pretreatment of adipocytes with U73122 （10×103 mM/L） blunted the decrease of MCP-1 after exposure 
to HNE. PAR-2 agonists （2-Furoyl-LIGRLO-amide and A264613） did not decrease MCP-1. HNE; human 
neutrophil elastase. Data were obtained from three donors in each group and represent the mean ±SE. 
*P< .01; **P< .05; N.S., not significant
a. b.
　1. 100 bp ladder 　2. β -Actin: HNE （0μM）
　3. MCP-1: HNE （0μM） 　4. MCP-1: HNE （50μM）
　5. MCP-1: U73122 （10mM） + HNE （50μM） 　6. MCP-1: 2-Furoyl-LIGRLO-amide （1 mM）
　7. MCP-1: AC 264613 （5 mM）
b. Visceral adipocytes were treated with HNE （50Μ）, 2-Furoyl-LIGRLO-amide （1 mM）, or AC 264613 （5 
mM） for 6 hr and then protein levels of MCP-1 were determined by ELISA. Data were obtained from 
three donors in each group and represent the mean ± SE. *P< .01; **P< .05; N.S., not significant
　1. no treatment  　2. HNE （50μM）
　3. 2-Furoyl-LIGRLO-amide （1 mM） 　4. AC 264613 （5 mM）
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Figure 6．Effect of PAR-2 siRNA on MCP-1 production by visceral adipocytes stimulated with HNE.
　Visceral adipocytes were transfected with PAR-2 siRNA and incubated with or without HNE （50μM） 
for 6 hr. MCP-1 protein levels in whole-cell lysates were measured by ELISA. HNE: human neutrophil 
elastase, MCP-1: monocyte chemotactic protein-1, PAR-2: protease-activated receptor 2, siRNA: small 
interfering RNA. Data were obtained from cells of three donors in each group and represent the mean ± 
SE. *P< .01; N.S., not significant
1. no treatment 
2. HNE （50μM）
3. PAR-2 siRNA （50 nM） + HNE （50μM）
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